Latest Ratios: P/E Ratio 184.1x · EV/EBITDA N/A · ROE -80.9%. (1996–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $281M | $265M | $213M | $190M | $214M | $257M | $215M | $255M | $281M | $283M | $223M |
| Enterprise Value | $329M | $312M | $302M | $317M | $324M | $382M | $362M | $398M | $431M | $465M | $417M |
| P/E Ratio → | 184.13 | — | 30.74 | 104.00 | 17.12 | 7.38 | 9.06 | 6.74 | 21.53 | — | 31.98 |
| P/S Ratio | 16.48 | 6.01 | 4.57 | 4.76 | 2.32 | 2.37 | 2.32 | 2.09 | 3.45 | 2.18 | 1.55 |
| P/B Ratio | 2.68 | 2.45 | 0.83 | 0.76 | 0.86 | 1.03 | 0.97 | 1.28 | 1.58 | 1.71 | 1.25 |
| P/FCF | — | 18.11 | — | — | — | — | — | 8.87 | 123.49 | 19.05 | 13.91 |
| P/OCF | 13.98 | 13.16 | — | — | 32.76 | 15.60 | 204.51 | 5.22 | 14.72 | 10.04 | 7.35 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 7.08 | 6.48 | 7.97 | 3.52 | 3.52 | 3.92 | 3.26 | 5.30 | 3.58 | 2.89 |
| EV / EBITDA | — | — | — | 28.11 | — | 12.92 | 17.09 | 6.77 | 17.73 | 50.89 | 11.21 |
| EV / EBIT | — | — | 20.85 | 43.06 | 19.89 | 7.58 | 9.70 | 6.94 | 19.84 | — | 19.11 |
| EV / FCF | — | 21.35 | — | — | — | — | — | 13.87 | 189.61 | 31.24 | 26.01 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -436.2% | -436.2% | -120.9% | 16.2% | -16.1% | 22.0% | 19.4% | 49.4% | 31.5% | 6.9% | 24.3% |
| Operating Margin | -462.7% | -462.7% | -144.6% | -10.5% | -27.0% | 13.3% | 7.5% | 37.0% | 13.0% | -4.7% | 15.2% |
| Net Profit Margin | -334.3% | -334.3% | 14.9% | 4.6% | 13.6% | 32.1% | 25.6% | 30.9% | 16.1% | -7.3% | 4.8% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -80.9% | -80.9% | 2.8% | 0.7% | 5.0% | 14.8% | 11.2% | 20.1% | 7.6% | -5.5% | 4.0% |
| ROA | -49.1% | -49.1% | 1.7% | 0.4% | 3.0% | 8.1% | 5.6% | 9.0% | 3.1% | -2.2% | 1.5% |
| ROIC | -61.1% | -61.1% | -14.0% | -0.9% | -5.1% | 2.9% | 1.5% | 10.1% | 2.3% | -1.3% | 4.4% |
| ROCE | -69.8% | -69.8% | -16.8% | -1.0% | -6.2% | 3.5% | 1.7% | 11.4% | 2.6% | -1.5% | 5.0% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.79 | 0.79 | 0.36 | 0.51 | 0.45 | 0.50 | 0.68 | 0.81 | 0.99 | 1.12 | 1.13 |
| Debt / EBITDA | — | — | — | 11.40 | — | 4.24 | 7.12 | 2.76 | 7.22 | 20.23 | 5.39 |
| Net Debt / Equity | — | 0.44 | 0.35 | 0.51 | 0.44 | 0.50 | 0.67 | 0.72 | 0.85 | 1.10 | 1.09 |
| Net Debt / EBITDA | — | — | — | 11.31 | — | 4.21 | 6.97 | 2.44 | 6.18 | 19.85 | 5.22 |
| Debt / FCF | — | 3.24 | — | — | — | — | — | 4.99 | 66.11 | 12.19 | 12.10 |
| Interest Coverage | -37.35 | -37.35 | 4.10 | 1.50 | 4.90 | 12.63 | 6.25 | 8.00 | 2.54 | -0.44 | 2.21 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.56 | 9.56 | 3.81 | 3.90 | 1.91 | 2.46 | 2.45 | 2.14 | 3.31 | 4.16 | 3.85 |
| Quick Ratio | 8.83 | 8.83 | 0.99 | 0.42 | 0.24 | 0.52 | 0.52 | 0.75 | 1.40 | 1.89 | 0.72 |
| Cash Ratio | 6.64 | 6.64 | 0.30 | 0.07 | 0.05 | 0.04 | 0.15 | 0.64 | 1.18 | 0.21 | 0.35 |
| Asset Turnover | — | 0.22 | 0.12 | 0.09 | 0.22 | 0.25 | 0.22 | 0.29 | 0.19 | 0.31 | 0.32 |
| Inventory Turnover | 55.99 | 55.99 | 3.42 | 0.64 | 3.85 | 1.95 | 1.83 | 1.54 | 1.36 | 3.34 | 1.87 |
| Days Sales Outstanding | — | 11.20 | 21.36 | 17.51 | 5.72 | 31.39 | 20.23 | 2.13 | 11.42 | 12.05 | 14.56 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 0.5% | 0.6% | 0.7% | 2.6% | 7.1% | 2.8% | 1.1% | 0.7% | 0.7% | 0.7% | 0.9% |
| Payout Ratio | — | — | 21.9% | 268.8% | 121.2% | 20.5% | 10.4% | 4.8% | 15.1% | — | 28.5% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 0.5% | — | 3.3% | 1.0% | 5.8% | 13.6% | 11.0% | 14.8% | 4.6% | — | 3.1% |
| FCF Yield | — | 5.5% | — | — | — | — | — | 11.3% | 0.8% | 5.2% | 7.2% |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 10.0% | 0.8% | 1.1% | 1.4% |
| Total Shareholder Yield | 0.5% | 0.6% | 0.7% | 2.6% | 7.1% | 2.8% | 1.3% | 10.8% | 1.5% | 1.8% | 2.3% |
| Shares Outstanding | — | $8M | $8M | $8M | $8M | $8M | $7M | $7M | $8M | $8M | $8M |
Includes 30+ ratios · 30 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ALCO stock.
Alico, Inc.'s current P/E ratio is 184.1x. The historical average is 28.6x. This places it at the 100th percentile of its historical range.
Alico, Inc.'s return on equity (ROE) is -80.9%. The historical average is 4.0%.
Based on historical data, Alico, Inc. is trading at a P/E of 184.1x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Alico, Inc.'s current dividend yield is 0.53%.
Alico, Inc. has -436.2% gross margin and -462.7% operating margin.
Key Metrics
Top Statement Risk
Impairment-distorted earnings base
Metrics are mathematically derived from official filings.
Book-Value Premium Against Loss-Making Peers
Alico trades at a 2.63x price-to-book ratio versus 0.99x for Limoneira and 1.35x for Mission Produce, while its negative trailing P/E of -1.93 renders the earnings multiple unusable, per the peer comparison table — a configuration that appears to price asset optionality rather than earnings.
The 2.22x forward EV/EBITDA sits far below the 9.1-15.8x range of profitable peers such as Papa John's, Mission Produce, and Calavo, but investors should treat this as an artifact of a depressed and highly episodic EBITDA base plus a large cash balance netted from enterprise value rather than evidence of deep value. Meanwhile, a 6.26x price-to-sales ratio against a business whose quarterly revenue ranged from roughly $0.8M to $18.0M over ten quarters suggests the market is underwriting grove land value or a return-of-capital thesis, not revenue quality — a gap versus peers that appears structural and warrants monitoring against per-acre asset realizations.
Margin Swings Obscure Earning Power
Quarterly gross margin has ranged from -100.2% in 2024Q2 to 44.8% in 2026Q3, while operating margin swung from -146.5% to 20.9% within four quarters, as shown in Alico's reported financials — a dispersion far too wide for any single quarter to represent normalized earning power.
Because SG&A has stayed within a narrow $2.3M-$3.4M band while revenue fluctuated with harvest timing, the operating line is driven overwhelmingly by cost recognition events — likely grove write-downs or biological asset adjustments — rather than underlying pricing or volume trends. Net margin of 23.5% in 2026Q3 also appears flattered by non-operating items, given that the prior quarter posted $11.4M of net profit against an operating loss; on a full-cycle view, cumulative gross losses of roughly $240.6M against about $92.9M of revenue over ten quarters imply that true earning power remains unproven, and investors should normalize across complete crop cycles rather than extrapolate recent quarters.
Returns Negative Across Capital Cycle
Alico's ROIC was negative in nine of the last ten quarters, bottoming at -41.2% in 2025Q2 before recovering to 1.5% in 2026Q3, according to the company's quarterly ratio disclosures — a level that still sits well below any plausible cost of capital for an agricultural landowner.
ROE of 2.0% in the latest quarter against a shareholders' equity base that has already been halved to $104.8M suggests the return profile is being supported by balance-sheet contraction rather than compounding; the denominator shrinkage from impairments mechanically flatters any recovery in returns. The efficiency driver is particularly weak: cumulative capex of roughly $21.2M compares with about $200.4M of depreciation and amortization over the same window, meaning the company is not reinvesting at the rate its asset base is being consumed, so the modest ROIC uptick may reflect a decaying capital base rather than improved productivity.
Cycle Compression Tied to Harvest Timing
The cash conversion cycle collapsed from 481 days in 2024Q4 to 11 days in 2026Q3, with DSO falling from 356 days to 14, per Alico's quarterly filings — a swing that appears driven by when harvest revenue is recognized rather than a durable improvement in working-capital discipline.
Asset turnover of 0.00-0.06 across all ten quarters confirms that this is an asset-value business rather than a volume business, and the near-zero readings mean that any valuation multiple anchored on revenue or asset productivity will produce wildly unstable conclusions quarter to quarter. The fact that 2026Q3's $7.1M of operating cash flow was roughly 92% attributable to working-capital release reinforces that the CCC improvement should be treated as cyclical timing; investors should monitor whether DSO settles at the current teens or reverts toward the historical 40-70 day range as subsequent harvests come through.
Idle Cash Cushion Exceeds Operating Need
Alico's current ratio stands at 7.96 with a quick ratio of 7.93 — virtually identical figures indicating almost no inventory dependence — and cash reserves of $55.6M against total debt of just $2.8M, based on recent SEC filings, a buffer that appears far in excess of the company's working-capital requirements.
This liquidity posture would comfortably absorb another crop-failure-style cost event such as the $167.7M charge recorded in 2025Q2, since short-term obligations are covered nearly eightfold by current assets and there is no meaningful near-term refinancing wall given debt-to-equity of 0.03. The counterpoint is that idle cash is a drag on returns: it depresses ROE (2.0% on a $104.8M equity base including $55.6M of cash) and helps explain why the market may be valuing Alico closer to its balance sheet than its operations, while the $10.0M deployed on buybacks across 2026Q2 and 2026Q3 suggests management is attempting to address that overhang.
Why P/E Misleads on Asset-Heavy Growers
The price-to-earnings ratio is the most commonly misapplied metric for Alico's business model: its trailing P/E of -1.93 is negative, and prior quarters swing between a $111.4M net loss and an $11.4M profit driven by non-operating gains and write-downs, per Alico's disclosures, making the multiple analytically inert.
For a land-rich citrus grower whose quarterly results are dominated by episodic grove revaluations, crop write-downs, and harvest-timing revenue recognition, reported net income captures accounting events rather than economic performance, so even a positive P/E would flatter or penalize the shares for reasons unrelated to grove productivity. A more defensible framework would normalize EBITDA across a full crop cycle or, better still, triangulate enterprise value against appraised per-acre grove land values net of debt — a land-NAV approach — since the current 2.63x price-to-book ratio and 6.26x price-to-sales ratio both reference book and revenue figures that have themselves been reset by the very write-downs that distort the earnings line.